US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 8, 2022 (4 years ago)

Sermorelin Acetate Lyophilized powder for reconstitution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Sub Potent

What was recalled

Sermorelin Acetate Lyophilized powder for reconstitution, Multi-Dose 9 mg per vial, Each ML contains: 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0059-00

Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
NDC code
73198-0059-00
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0718-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sermorelin recalls

See all
Class II · Moderate risk Terminated

Sermorelin Acetate 1 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0781-2022
Class II · Moderate risk Terminated

Ipamorelin Acetate/Sermorelin Acetate

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0777-2022